SHZ · 002099.SZ
Zhejiang Hisoar Pharmaceutical Co., Ltd.
CN¥5.54-CN¥0.26 (-4.48%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.05% below the high.
Loading market information…
SHZ · 002107.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shandong Wohua Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shandong Wohua Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.23 per share, paid semi-annual. The forward yield is 4.02% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shandong Wohua Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shandong Wohua Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, production, and distribution of a broad array of medicinal products across the country. The company's extensive product portfolio addresses various therapeutic categories. Key offerings include Xinkeshu tablets, Naoxueshu oral solutions, and Tongluo Huayu capsules, which are specifically formulated for cardiovascular and cerebrovascular health. Beyond these, Shandong Wohua also supplies medications for respiratory conditions, drugs targeting the urinary and digestive systems, anti-rheumatic treatments, and sedative agents. Furthermore, it provides specialized pharmaceuticals tailored for women and children. Headquartered in Weifang, China, the company operates as a subsidiary under the ownership of Beijing Zhongzheng Wanrong Investment (Group) Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥5.54-CN¥0.26 (-4.48%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.05% below the high.
CN¥5.18-CN¥0.09 (-1.71%)
Daan Gene Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.83% below the high.
CN¥4.34+CN¥0.01 (+0.23%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.81% below the high.
CN¥4.98-CN¥0.03 (-0.6%)
Beijing SL Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.02% below the high.
CN¥3.96-CN¥0.03 (-0.75%)
Luoxin Pharmaceuticals Group Stock Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.96% below the high.
CN¥7.67+CN¥0.02 (+0.26%)
Beijing Science Sun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.42% below the high.
CN¥2.54-CN¥0.04 (-1.55%)
Huaren Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.18% below the high.
CN¥4.72-CN¥0.11 (-2.28%)
Baotou Dongbao Bio-Tech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 30.79% below the high.
